Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study-Reference-Cited by-同舟云学术

Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study

Published:2015-10-09 Issue:4 Volume:109 Page:249-256
ISSN:1460-2725
Container-title:QJM
language:en
Short-container-title:QJM

Author:

Morling J.R.,Fallowfield J.A.,Guha I.N.,Williamson R.M.,Ali M.,Glancy S.,Strachan M.W.J.,Price J.F.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/qjmed/article-pdf/109/4/249/6867808/hcv191.pdf

Reference28 articles.

1. Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?

2. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

3. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort

4. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors

5. Davies S. Chief Medical Officer annual report 2011: Vol. 1, Chapter 2c, p.163. Department of Health, 2012. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/141773/CMO_Annual_Report_2011_Chapter_2c.pdf (1 July 2015, date last accessed).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group;The Lancet Gastroenterology & Hepatology;2022-08

2. Theoretical investigation on the interaction between Metformin and Ferulic acid - A DFT approach;Journal of the Indian Chemical Society;2022-03

3. Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians;Hepatobiliary Surgery and Nutrition;2021-02

4. Non‐invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study;Liver International;2020-07-22

5. Incidence and causes of mildly to moderately elevated aminotransferase in Japanese patients with type 2 diabetes;Diabetology International;2019-08-14